Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Conversion in Stable Kidney Transplant Recipients
NCT02963103Phase 4Terminated
- Sponsor
- Astellas Pharma
- Start
- May 2010
- Primary completion
- Oct 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus + Wuzhi capsule in kidney transplantation, sponsored by Astellas Pharma. Primary endpoint: Change from baseline in Glomerular Filtration Rate at Week 24. Started May 2010; status: terminated.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT02963103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02963103.